What is the new drug for NF1?
•
4 min read
Affecting approximately 1 in every 3,000 to 4,000 people, Neurofibromatosis type 1 (NF1) is a genetic disorder that can cause tumors to grow on nerves [1.5.7]. The newest answer to 'What is the new drug for NF1?' is mirdametinib (Gomekli), approved by the FDA in February 2025 [1.2.1].
